Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.670
-0.050 (-2.91%)
Feb 21, 2025, 4:00 PM EST - Market closed
Phio Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 6 | 2 | 5 | 14 | 16 | 6 | |
| Market Cap Growth | -11.49% | -63.48% | -62.43% | -12.96% | 146.99% | 5.09% | |
| Enterprise Value | 0 | -6 | -9 | -13 | -1 | -2 | |
| Last Close Price | 1.67 | 6.84 | 40.18 | 108.00 | 290.52 | 1015.74 | |
| Forward PE | 2.44 | 0.21 | 0.37 | 2.19 | - | - | |
| PS Ratio | - | - | - | - | - | 299.79 | |
| PB Ratio | 0.32 | 0.24 | 0.47 | 0.62 | 1.19 | 1.10 | |
| P/TBV Ratio | 0.60 | 0.24 | 0.47 | 0.62 | 1.19 | 1.10 | |
| Debt / Equity Ratio | - | 0.00 | 0.02 | 0.01 | 0.05 | 0.09 | |
| Asset Turnover | - | - | - | - | - | 0.00 | |
| Quick Ratio | 5.87 | 5.20 | 6.08 | 7.84 | 6.49 | 3.69 | |
| Current Ratio | 6.38 | 5.71 | 6.42 | 8.06 | 6.91 | 3.88 | |
| Return on Equity (ROE) | -122.03% | -116.60% | -70.06% | -76.04% | -93.73% | -92.19% | |
| Return on Assets (ROA) | -60.11% | -59.86% | -37.72% | -41.28% | -46.22% | -48.09% | |
| Return on Capital (ROIC) | -75.72% | -70.71% | -43.11% | -47.06% | -55.16% | -56.61% | |
| Earnings Yield | -130.43% | -582.98% | -225.79% | -98.17% | -56.55% | -141.50% | |
| FCF Yield | -142.59% | -579.10% | -240.93% | -87.99% | -56.73% | -138.46% | |
| Buyback Yield / Dilution | -226.77% | -83.32% | -6.30% | -179.70% | - | - | |
| Total Shareholder Return | -226.77% | -83.32% | -6.30% | -179.70% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.